CD8A and neoplasm: This signature is mechanistically anchored in polarized tumor immune microenvironments: low-risk patients exhibit an antitumor milieu enriched with cytotoxic CD8+ T cells, Tfh cells, and M1 macrophages, while high-risk patients display an immunosuppressive phenotype showing higher proportions of Tregs and M2 macrophages.